Tate & Lyle (TATYY) AI Stock Analysis

• Market Cap: $2.75B
• Dividend Yield: 3.64%
• Average Volume (3M): 17.00
• Price to Earnings (P/E): 11.5
• Beta (1Y): 0.56
• Revenue Growth: -7.98%
• EPS Growth: 0.71%
• Country: US
• Employees: 3,318
• Sector: Consumer Defensive
• Sector Strength: 86
• Industry: Packaged Foods
• EPS (TTM): 2.13
• Shares Outstanding: 111,357,414
• 10 Day Avg. Volume: 51
• 30 Day Avg. Volume: 17
• PEG Ratio: 16.25
• Price to Book (P/B): N/A
• Price to Sales (P/S): 1.44
• Price to Cash Flow (P/CF): N/A
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Tate & Lyle's stock score reflects solid financial performance with strong profitability and a robust balance sheet. However, bearish technical indicators and recent revenue declines weigh down the overall score. The reasonable valuation and attractive dividend yield provide some support, suggesting potential for long-term investors if revenue growth stabilizes.

Tate & Lyle Business Overview & Revenue Model

Company Description

Tate & Lyle PLC is a global provider of food and beverage ingredients and solutions. The company operates in two main segments: Food & Beverage Solutions and Sucralose. Tate & Lyle's core products include sweeteners, texturants, and health and wellness solutions designed to improve the nutritional profile of food and beverages. With a rich heritage in ingredient innovation, Tate & Lyle collaborates with manufacturers worldwide to meet the demands of consumers for healthier and tastier products.

How the Company Makes Money

Tate & Lyle makes money primarily through the sale of its food and beverage ingredients and solutions. The company's revenue model is centered around its two main segments: Food & Beverage Solutions and Sucralose. In the Food & Beverage Solutions segment, Tate & Lyle generates income by providing sweeteners, texturants, and other specialty ingredients to food and beverage manufacturers. This segment is focused on innovation and meeting the growing consumer demand for healthier products. The Sucralose segment contributes to the company's earnings by producing and selling sucralose, a zero-calorie sweetener, to various markets. Key revenue streams for Tate & Lyle include direct sales to manufacturers, strategic partnerships, and long-term supply agreements. The company's financial performance is influenced by factors such as global demand for health-oriented food products, commodity prices, and its ability to innovate and adapt to consumer trends.

Tate & Lyle Financial Statement Overview

Summary

Tate & Lyle demonstrates solid financial performance with strong profitability margins and stable leverage, despite recent revenue declines. The company's balance sheet is robust with a solid equity base while cash flows indicate efficient operations and strong cash generation. Focus on revenue growth and optimizing asset use could further enhance financial health.

Income Statement

The company exhibits a strong gross profit margin of 51.68% and a healthy net profit margin of 11.41% for the latest period. However, year-over-year revenue declined by 5.93%, indicating possible market challenges. Despite this, the EBIT and EBITDA margins remain solid at 12.57% and 20.95%, respectively, reflecting efficient operations.

Balance Sheet

The balance sheet indicates a stable equity ratio of 54.26%, suggesting a well-capitalized structure. The debt-to-equity ratio is manageable at 0.48, which shows prudent leverage levels. However, return on equity has slightly decreased to 15.19%, signaling a need for improved profitability or asset utilization.

Cash Flow

The cash flow statement reveals a strong operating cash flow to net income ratio of 1.11, suggesting efficient cash generation relative to earnings. Free cash flow growth is robust at 145.00%, but free cash flow as a proportion of net income, at 0.52, leaves room for improvement.

Breakdown
TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
1.76B	1.65B	1.75B	1.38B	1.21B	2.88B
	Gross Profit
1.76B	851.00M	496.00M	339.00M	303.00M	892.00M
	EBIT
205.00M	207.00M	226.00M	166.00M	157.00M	317.00M
	EBITDA
300.00M	345.00M	321.00M	168.00M	292.00M	501.00M
	Net Income Common Stockholders
171.00M	188.00M	190.00M	236.00M	253.00M	245.00M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
290.00M	437.00M	475.00M	110.00M	371.00M	271.00M
	Total Assets
2.79B	2.28B	2.51B	3.25B	2.97B	2.85B
	Total Debt
595.00M	590.00M	713.00M	679.00M	788.00M	722.00M
	Net Debt
310.00M	153.00M	238.00M	569.00M	417.00M	451.00M
	Total Liabilities
1.30B	1.04B	1.32B	1.63B	1.51B	1.45B
	Stockholders Equity
1.49B	1.24B	1.19B	1.62B	1.45B	1.40B
Cash Flow		Free Cash Flow
83.00M	98.00M	40.00M	-11.00M	222.00M	259.00M
	Operating Cash Flow
174.00M	208.00M	118.00M	137.00M	374.00M	425.00M
	Investing Cash Flow
-56.00M	-20.00M	783.00M	-147.00M	-210.00M	-169.00M
	Financing Cash Flow
-197.00M	-215.00M	-598.00M	-247.00M	-29.00M	-273.00M

Tate & Lyle Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 25.85
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TATYY, the sentiment is Negative. The current price of 25.85 is below the 20-day moving average (MA) of 26.77, below the 50-day MA of 28.23, and below the 200-day MA of 33.15, indicating a bearish trend. The MACD of -0.51 indicates Negative momentum. The RSI at 40.77 is Neutral, neither overbought nor oversold. The STOCH value of 25.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TATYY.

Tate & Lyle Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
POST	75 Outperform	$6.55B	19.44	10.01%	―	7.32%	34.44%
INGR	74 Outperform	$8.22B	13.19	17.62%	2.47%	-8.95%	1.35%
CAG	70 Outperform	$12.26B	37.59	3.67%	5.45%	-3.15%	-65.38%
JJSF	64 Neutral	$2.60B	30.77	9.08%	2.32%	2.14%	5.38%
Sector *	63 Neutral	$20.41B	13.98	-16.01%	3.26%	1.30%	5.01%
TATYY	61 Neutral	$2.75B	11.51	12.10%	3.64%	-7.98%	0.71%
SJM	61 Neutral	$12.25B	22.22	-3.55%	3.74%	7.07%	-181.54%